ETOPOSIDE (VP-16-213) IN MALIGNANT BRAIN-TUMORS - A PHASE-II STUDY

被引：89

作者：

TIRELLI, U

DINCALCI, M

CANETTA, R

TUMOLO, S

FRANCHIN, G

VERONESI, A

GALLIGIONI, E

TROVO, MG

ROSSI, C

GRIGOLETTO, E

机构：

[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY

[2] BRISTOL MYERS CO,DIV PHARMACEUT RES & DEV,NEW YORK,NY

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 05期

关键词：

D O I：

10.1200/JCO.1984.2.5.432

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：432 / 437

页数：6

共 29 条

[1]

CAVALLI F, 1982, CANCER CHEMOTH PHARM, V7, P81

[2]

COLOMBO T, 1982, CANCER CHEMOTH PHARM, V7, P127

[3]

CREAVEN PJ, 1975, CLIN PHARMACOL THER, V18, P227

[4]

CREAVEN PJ, 1975, CLIN PHARMACOL THER, V18, P221

[5]

CREAVEN PJ, 1982, CANCER CHEMOTH PHARM, V7, P133

[6]

DINCALCI M, 1982, CANCER CHEMOTH PHARM, V7, P141

[7] COMBINATION CHEMOTHERAPY WITH 4' DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE), VP-16-213 (NSC-141540) IN L1210 LEUKEMIA [J].

DOMBERNOWSKY, P ;

NISSEN, NI .

EUROPEAN JOURNAL OF CANCER, 1976, 12 (03) :181-188

[8]

DREWINKO B, 1979, CANCER TREAT REP, V63, P373

[9] PHASE-II STUDIES OF DIANHYDROGALACTITOL-BASED COMBINATION CHEMOTHERAPY FOR RECURRENT BRAIN-TUMORS [J].

EAGAN, RT ;

CREAGAN, ET ;

BISEL, HF ;

LAYTON, DD ;

GROOVER, RV ;

HERMAN, RC .

ONCOLOGY, 1981, 38 (01) :4-6

[10]

EDWARDS MS, 1980, CANCER TREAT REP, V64, P1179

← 1 2 3 →